HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gino Gerosa Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tarantini, G. Articles by Iliceto, S. Search for Related Content PubMed PubMed Citation Articles by Tarantini, G. Articles by Iliceto, S. Related Collections Valve disease

Eur J Cardiothorac Surg 2003;24:879-885
© 2003 Elsevier Science NL

Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery

Department of Cardiology and Cardio-thoracic Surgery, Policlinico Universitario, University of Padua, Via Giustiniani 2, 35128 Padua, Italy

Received 3 July 2003; received in revised form 20 August 2003; accepted 26 August 2003.

^* Corresponding author. Tel.: +39-049-8212310; fax: +39-049-8761764
e-mail: giuseppe.tarantini.1{at}unipd.it

	Abstract

Top Abstract 1. Introduction 2. Material and methods 3. Results 4. Discussion References

 
Objective: The influence of left ventricular (LV) dysfunction on survival of patients with severe aortic stenosis is poorly characterized. Few data are available about preoperative predictors of cardiac mortality and LV function recovery after aortic valve replacement of such patients. The aim of our study was to examine the outcome and the preoperative predictors of postoperative cardiac death and of LV function recovery in these patients. Methods: We evaluated 85 consecutive patients with severe aortic stenosis (aortic valve area <1 cm²) and severe depression of LV ejection fraction (EF) <35% at cardiac catheterization. Among them, 52 underwent aortic valve replacement and they were compared to patients who were not operated on. All patients had a mean clinical follow-up of 53 months and 94% of them had a mean echocardiographic follow-up of 14 months after aortic valve replacement. Results: The mean baseline characteristics included: LVEF 28±6%, peak-to-peak transvalvular gradient 51±29 mmHg, aortic valve area 0.63±0.25 cm². Thirty-three patients did not undergo aortic valve replacement: 32 of them died within 3 years. Fifty-two patients underwent aortic valve replacement and 16 had a concomitant coronary bypass surgery. In-hospital mortality was 8%. Postoperative NYHA functional class changed from 2.84±0.67 to 1.43±0.44 (P<0.001) and LVEF from 29±6% to 43±10% (P<0.001). At follow-up 10 patients died of heart disease. By multivariate analysis, preoperative LV end-systolic volume index (ESVI) was the only covariate of cardiac death (LVESVI/10 ml/m², OR 1.3, CI 1.1–1.8, P<0.028). By using a receiver operating characteristic curve, LVESVI90 ml/m² was the best cut-off value (sensitivity and specificity 78%) to fit with a better survival (93% vs. 63%, P<0.01) and with LVEF recovery after aortic valve replacement (EF improved by 15±10% vs. 8±5%, P<0.001). Conclusions: Despite LV dysfunction, aortic valve replacement appears to change drastically the natural history of severe aortic stenosis. Preoperative LV levels predict different postoperative survival rate and LVEF recovery.

Key Words: Aortic stenosis • Surgery • Survival • Ventricular function

	1. Introduction

Top Abstract 1. Introduction 2. Material and methods 3. Results 4. Discussion References

 
Severe aortic stenosis carries a poor prognosis when associated with congestive heart failure, the average life expectancy being of less than 2 years without surgical correction [1–3]. Accordingly, despite aortic valve replacement represents the only effective treatment, few data are available on long term survival and changes in systolic function of patients operated after the occurrence of a severe left ventricular (LV) systolic dysfunction [4–6]. Excessive LV afterload may be promptly reversed by aortic valve replacement while, in the presence of a severe contractile impairment (‘valvular cardiomyopathy’), LV dysfunction may persist after aortic valve replacement [7]. Thus, differences in the mechanisms determining ventricular dysfunction can markedly influence postoperative recovery of cardiac function and patient's survival.

Predictors of postoperative survival and LV function after aortic valve replacement for severe aortic stenosis with LV dysfunction have not been clearly identified. Therefore, we hypothesized that the rate of postoperative cardiac death and LV function recovery could be related to preoperative indexes of LV dysfunction representative of prevalent myocardial damage rather than afterload mismatch. The aim of this study was to examine the outcome of these patients and to further assess potential preoperative predictors of postoperative cardiac death and LV function recovery.

	2. Material and methods

Top Abstract 1. Introduction 2. Material and methods 3. Results 4. Discussion References

 
2.1. Study population
From the hemodynamic database of our tertiary referral center, we identified all patients from February 1986 to November 2001 who had an aortic valve area <1 cm², LV ejection fraction (EF) <35%. Patients were excluded if they were <18 years old, had more than moderate (>2+/4) aortic or mitral regurgitation by echocardiography or angiography, had undergone valve replacement or repair previously, or required any valve replacement in addition to aortic valve replacement during the operation. Coronary artery disease was not an exclusion factor. The medical records of 85 consecutive patients who fulfilled the entry criteria for the study were reviewed, including preoperative clinical data, 2D and Doppler transthoracic echocardiographic results, cardiac catheterization hemodynamics and coronary anatomy, and when present operative data.

2.2. Echocardiographic methods
All patients underwent comprehensive 2D and Doppler transthoracic echocardiographic assessment, 64 (75%) patients in our institution and 21 (25%) in other hospitals, <30 days before admission for cardiac catheterization. LVEF were determined by volumetric methods [8]. Aortic valve hemodynamic data were assessed using standard methods, and the aortic valve area was calculated with the continuity equation [9]. Mitral and aortic regurgitation was semiquantitated from 0 (none) to 4+ (severe) by analysis of color flow Doppler [10,11]. All postoperative studies were performed with echocardiography. Median time from surgery to postoperative echocardiography was 14.1 months.

2.3. Angiographic methods
In our center, preoperative hemodynamic assessment of adult aortic stenosis included right and left cardiac catheterization and coronary angiography in all patients. With fluid filled catheter, LV and systemic arterial pressures were recorded simultaneously. Cardiac output and index were measured at the time of cardiac catheterization, and aortic valve area was calculated from the Gorlin equation [12]. Peak-to-peak transvalvular gradient was used. Cardiac output was determined by the Fick method. All patients underwent aortography at 60° left anterior oblique view to evaluate aortic insufficiency. From left ventriculography, end-diastolic volume index (EDVI), end-systolic volume index (ESVI) and EF were calculated by the area-length method with the correction for 30° right anterior oblique projection [13]. Mitral and aortic regurgitation were semiquantitated from 0 (none) to 4+ (severe) [14]. Selective coronary angiography was performed in different angled projections. Coronary artery disease was defined as 70% lumen diameter narrowing of the left main or major epicardial vessels. Multivessel coronary artery disease was defined as either left main or two or three major epicardial vessel disease. When both preoperative echocardiographic and ventriculographic data of LVESVI, LVEDVI and LVEF were available, the angiographic value were used for statistical analysis. The mean difference in LVEF between modalities was 1% (P<0.35).

2.4. Surgical procedures
Fifty-two patients (61%) underwent aortic valve replacement. All surgical records were reviewed in order to determine the type and size of aortic valve prosthesis and to show whether coronary artery bypass graft surgery was performed concomitantly with aortic valve replacement. The surgical procedures performed, along with cross-clamp and cardiopulmonary bypass times, were included in database for the analysis. In-hospital death was defined as death before hospital discharge. After discharge, death were classified as either cardiac or non-cardiac. Deaths for which a non-cardiac cause was no clearly documented were considered to be cardiac related.

2.5. Statistical analysis
Data are expressed as mean value±standard deviation for continuous variables, as numbers with percentage for categorical variables. The paired and unpaired Student test was performed to determine intragroup and intergroup differences between mean values for continuous variable, as appropriate. Categorical variables were analyzed by chi-square test or Fisher's exact test as appropriate. Multivariate logistic models were fit to identify preoperative variables related to postoperative cardiac death. Overall survival and death not due to heart disease were estimated by the use of the Kaplan–Meier method. Receiver operating characteristic (ROC) curve analysis was performed to establish the diagnostic accuracy and the value of preoperative end systolic volume index as predictor of cardiac death. Comparison of intergroup changes between preoperative and postoperative echocardiographic values used the non-parametric Mann–Whitney U-test. A P value <0.05 was considered significant. Data were analyzed with SPSS for Windows, release 10 (SPSS Inc., Chicago, IL).

	3. Results

Top Abstract 1. Introduction 2. Material and methods 3. Results 4. Discussion References

 
Baseline clinical and electrocardiographic data are outlined in Table 1. Preoperative hemodynamic and angiographic data are shown in Table 2. Fifty-two patients of 85 (61%) underwent aortic valve replacement and 31% of them (16/52) received a concomitant coronary artery by-pass graft. Thirty-three patients of 52 (39%) refused operation: all of them died within 40 months (Fig. 1) . In-hospital mortality in operated patients was 8% (4/52), three patients died of cardiac death, due to low cardiac output. We failed to identify independent predictors of in-hospital mortality.

View larger version (13K): [in this window] [in a new window]   Fig. 1. Kaplan–Meier cardiac survival curves, a comparison of patients operated versus non-operated. AVR, aortic valve replacement.

View larger version (12K): [in this window] [in a new window]   Fig. 2. The value of angiographic LVESVI for which sensitivity and specificity were equal was 92 ml/m2. LVESVI, left ventricular end-systolic volume index.

View larger version (19K): [in this window] [in a new window]   Fig. 3. Kaplan–Meier cardiac survival curves following surgery, a comparison of patients with preoperative LVESVI90 ml/m2 versus >90 ml/m2. LVESVI, left ventricular end-systolic volume index.

	4. Discussion

Top Abstract 1. Introduction 2. Material and methods 3. Results 4. Discussion References

4.1. Non-operated patients
In our study all non-operated patients died within 40 months. This is in agreement with the common knowledge about the fate of severe aortic stenosis: a rapid death after the onset of heart failure. Although their profile is not completely super imposable to that of operated patients, they still have a severe aortic stenosis (aortic valve area 0.7±0.3 cm²), a virtually identical LVEF (28%) and a smaller, but still significant, transaortic gradient (45 mmHg). Since the majority of non-operated patients were hypertensive, an elevated arterial pressure at the moment of cardiac catheterization could well have decreased the gradient contributing to underestimate stenosis severity. In summary, this group seems to be very similar in many aspects to that of operated patients. Thus, we may consider the latter as control group.

4.2. Survival after aortic valve replacement and predictors of cardiac death
Operated patients have a narrower valve and less comorbidities respect to non-operated patients. They showed a low perioperative mortality of 8% and an improved survival at long term follow-up. These findings are similar to those in previous series; however, there is only the report of Connolly [6] on surgical or late outcome in a large group of patients with aortic stenosis and substantial LV dysfunction. Many of the reported series have included patients undergoing aortic valve replacement for both aortic regurgitation and aortic stenosis [15,16]. Furthermore, the other reported surgical series are largely older series, and surgical techniques, particularly regarding myocardial preservation, have advanced since that time. In the report of Connolly early mortality was 9% and related, by multivariate analysis, to the presence of coronary artery disease, while late mortality was related to the presence of coronary artery disease in addition to preoperative cardiac output. Since all patients had reduced LV function, further LVEF analysis was not related to survival. As we know from physiology, not all LVEF are created equally, so, in our study, we included LVEF, LVESVI, LVEDVI as potential covariates of outcome hypothesizing that postoperative survival and recovery of LV function might be related to preoperative indexes of LV dysfunction representative of prevalent myocardial damage rather than afterload mismatch. By multivariate analysis, we failed to find independent predictors of in-hospital mortality while LVESVI resulted as independent covariate of total cardiac mortality. In our series, coronary artery disease was less frequent than that reported by Connolly and was treated successfully in all cases. LVESVI is a well established prognostic indicator in patients with mitral or aortic regurgitation, even if LVEF is normal. Such patients appear to represent a high risk group with an increased incidence of sudden death if not operated on, and with a considerable postoperative mortality once symptoms and/or LV systolic dysfunction developed [17]. Although LVESVI does not intervene as criteria for valve replacement in severe aortic stenosis, it remains a significant prognostic indicator, in the subgroup of patients with severe aortic stenosis and LV dysfunction.

4.3. LV function after aortic valve replacement
In our study, aortic valve replacement was associated with improved LVEF, as shown by others [3,18]. We also studied the relation between preoperative LVESVI and the extent and type of LV function recovery. After aortic valve replacement, LVEF increased markedly, due to a decrease in LVESVI, while LVEDVI remained unchanged. Although the LV volumes have been evaluated and analyzed largely by cineangiography before surgery, and by echocardiogram thereafter, we think that our study findings remain essentially true. LVEF is a non-dimensional parameter, therefore its evaluation is largely independent from the instrumentation used for measuring it. Previous studies have documented acceptable correlations between angiography and echocardiography and have confirmed reproducibility [19,20]. Indeed the mean difference in preoperative LVEF between modalities was 1% (P<0.37). Thus, we are almost sure that EF is actually increased after aortic valve replacement. Problems can arise as far as evaluation of absolute volumes is concerned, because volumes are not dimensionless. However, whatever the means of measurement, changes in LVESVI are much more marked than changes in EDVI, and, since pumping ability is certainly increased, as explained before, we can reasonably hypothesize that increased EF is most probably due to a decrease in LVESVI, without affecting preload significantly. Depending on angiographic LVESVI, we found differences between pre- and postoperative LVESVI and also between pre- and postoperative LVEF. This difference lessens in the group of patients with smaller to those with larger LVESVI, determining a gradient of LV function recovery as expressed by LVEF changes. Although LVEDVI did not change significantly, all patients showed a reduction of LVESVI during follow-up, but changes were still prevalent in the group with smaller preoperative LVESVI. Since at end systole volume is essentially independent of preload and is apparently dependent only upon contractile state and loading condition, we may reasonably consider this behavior to be teleologically explained by a prevalent ‘afterload mismatch’ as cause of LV dysfunction in the group of patients with mild LV dilatation; in contrast patients with large preoperative LV volume showed less benefit in terms of LVEF and LVESVI changes, which may be reasonably explained by prevalent myocardial damage instead of afterload mismatch. The case of ‘valvular cardiomyopathy’ may be considered in the latter group [7] with a long term survival trend similar to that reported recently among community subjects in the Framingham Heart Study after the onset of heart failure [21].

In conclusion, we maintain that severe aortic stenosis rarely has clinical contraindications to surgery for cardiac reasons and, even in severely ill patients, the surgical risk is surprisingly low. In-hospital survival does not seem to depend on LV function, although late survival does. Postoperative improvement of LV function is related to preoperative LVESVI, but LVESVI improvement is less in patients with smaller to those with larger preoperative LVESVI determining a gradient of LV function recovery as expressed by LVEF changes. Evaluation of LV function before surgery should include LVESVI measurement, which gives insight both on late survival and LV function recovery after aortic valve replacement in such patients.

4.4. Limitations
This is a retrospective case-series study of consecutive patients admitted to a single center and monitored for nearly 20 years. Our patients represent a ‘relatively’ small sample size because severe aortic stenosis and left ventricular dysfunction is a rare association, in fact only a few larger series of such patients can be found in literature.

The two groups of patients (i.e. operated and not operated on) are not statistically matched because of the small sample size; however, most of the major prognostic variables are comparable between the two groups (i.e. age, gender, LVEF, CAD, etc.). In spite that the number of patients is small, we were able to demonstrate significant differences in mortality rate and left ventricular function recovery.

At echocardiographic follow-up we lost three out of 52 patients; this should be considered in the interpretation of results, since performing echocardiography may have been an indicator for better outcome.

	Acknowledgments

 
We are indebted to the technicians and to the nurses of the catheterization laboratory for their continuous enthusiasm and professional performance. We also acknowledge the support of Barbara Hildenbrand in the editing of the manuscript.

	References

Top Abstract 1. Introduction 2. Material and methods 3. Results 4. Discussion References

 

1. Ross J., Braunwald E. Aortic stenosis. Circulation 1968;38(suppl. 1):61-67.
2. Schwarz F., Baumann P., Manthey J., Hoffmann M., Schuler G., Mehmel H.C., Schmitz W., Kubler W. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-1110.[Abstract/Free Full Text]
3. Pereira J.J., Lauer M.S., Bshir M., Afridi I., Blackstone E.H., Stewart W.J., McCarthy P.M., Thomas J.D., Asher C.R. Survival after aortic valve replacement for severe aortic stenosis with low transvalvelar gradients and severe left ventricular dysfunction. J Am Coll Cardiol 2002;39:1356-1363.[Abstract/Free Full Text]
4. Smith N., McAnulty J.H., Rahimtoola S.H. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978;58:255-264.[Abstract/Free Full Text]
5. Carabello B.A., Green L.H., Grossman W., Cohn L.H., Koster J.K., Collins J.J., Jr Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 1980;62:42-48.[Free Full Text]
6. Connolly H.M., Oh J.K., Orszulak T.A., Osborn S.L., Roger V.L., Hodge D.O., Bailey K.R., Seward J.B., Tajik A.J. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction: prognostic indicators. Circulation 1997;95:2395-2400.[Abstract/Free Full Text]
7. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., Nordet P. Report of the 1995 World Health organization/International Society and Federation of Cardiology Task Force on the definition and classification of Cardiomyopathies. Circulation 1996;93:841-842.[Free Full Text]
8. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.[Medline]
9. Oh J.K., Taliercio C.P., Holmes D.R., Reeder G.S., Bailey K.R., Seward J.B., Tajik A.J. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol 1988;11:1227-1234.[Abstract]
10. Helmcke F., Nanda N.C., Hsiung M.C., Soto B., Adey C.K., Goyal R.G., Gatewood R.P., Jr Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183.[Abstract/Free Full Text]
11. Perry G.J., Helmcke F., Nanda N.C., Byard C., Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol 1987;9:952-959.[Abstract]
12. Gorlin R., Gorlin S.G. Hydraulic formula for calculation of the area of the stenotic mitral valve, ther cardiac valves, and central circulatory shuts. Am Heart J 1951;41:1-29.[CrossRef][Medline]
13. Kennedy J.W., Treholme S.E., Kasser I.S. LV volume and mass from single plane cineangiogram: a comparison of anteroposterior and right anterior oblique methods. Am Heart J 1970;80:343-353.[CrossRef][Medline]
14. Sellers R., Levy M., Amplatz K. Left retrograde cardioangiography in acquired cardiac disease. Am J Cardiol 1964;14:437-447.[CrossRef][Medline]
15. Mullany C.J., Elveback L.R., Frye R.L., Edwards W.D., Orszulak T.A., Nassef L.A., Jr, Riner R.E., Danielson G.K. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. J Am Coll Cardiol 1988;10:66-72.
16. Magovern J.A., Pennock J.L., Campbell D.B., Pae W.E., Bartholomew M., Pierce W.S., Waldhausen J.A. Aortic valve replacement and combined aortic valve replacement and coronary artery bypass grafting: predicting high risk groups. J Am Coll Cardiol 1987;9:38-43.[Abstract]
17. Carabello B., De Leon A.C., Edmunds L.H., Jr, Fedderly B.J., Freed M.D., Gaasch W.H., McKay C.R., Nishimura R.A., O'Gara P.T., O'Rourke R.A., Rahimtoola S.H., Ritchie J.L., Cheitlin M.D., Eagle K.A., Gardner T.J., Garson A., Jr, Gibbons R.J., Russell R.O., Ryan T.J., Smith S.C., Jr ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-1588.[Free Full Text]
18. Rothenburger M., Drebber K., Tjan T.D.T., Schmidt C., Schmid C., Witcher T., Scheld H.H., Deiwick M. Aortic valve replacement for aortic regurgitation and stenosis, in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 2003(5):703-709.
19. Fast J., Jacobs S. Limits of reproducibility of cross-sectional echocardiographic measurement of left ventricular ejection fraction. Int J Cardiol 1990;28:67-72.[CrossRef][Medline]
20. Enriquez-Sarano M., Tajik A.J., Schaff H.V., Orszulak T.A., Bailey K.R., Frye R.L. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-837.[Abstract/Free Full Text]
21. Levy D., Kenchaiah S., Larson M.G., Benjamin E.J., Kupka M.J., Ho K.K., Murabito J.M., Vasan R.S. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402.[Abstract/Free Full Text]

This article has been cited by other articles:

				M. E. Halkos, E. P. Chen, E. L. Sarin, P. Kilgo, V. H. Thourani, O. M. Lattouf, J. D. Vega, C. D. Morris, T. Vassiliades, W. A. Cooper, et al. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. Ann. Thorac. Surg., September 1, 2009; 88(3): 746 - 751. [Abstract] [Full Text] [PDF]

				W.-H. Ding, Y.-Y. Lam, A. Duncan, W. Li, E. Lim, M. G. Kaya, R. Chung, J. R. Pepper, and M. Y. Henein Predictors of survival after aortic valve replacement in patients with low-flow and high-gradient aortic stenosis Eur J Heart Fail, September 1, 2009; 11(9): 897 - 902. [Abstract] [Full Text] [PDF]

				E. L. Hannan, Z. Samadashvili, S. J. Lahey, C. R. Smith, A. T. Culliford, R. S.D. Higgins, J. P. Gold, and R. H. Jones Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality. Ann. Thorac. Surg., June 1, 2009; 87(6): 1741 - 1749. [Abstract] [Full Text] [PDF]

				E. Bovill, S. Westaby, A. Crisp, S. Jacobs, and T. Shaw Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 853 - 861. [Abstract] [Full Text] [PDF]

				J Bermejo and R Yotti Low-gradient aortic valve stenosis: value and limitations of dobutamine stress testing Heart, March 1, 2007; 93(3): 298 - 302. [Abstract] [Full Text] [PDF]

				A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, D. Nercolini, S. Tapiero, P.-Y. Litzler, J.-P. Bessou, and V. Babaliaros Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve: Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1214 - 1223. [Abstract] [Full Text] [PDF]

				A. Chukwuemeka, V. Rao, S. Armstrong, J. Ivanov, and T. David Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 133 - 138. [Abstract] [Full Text] [PDF]

				H Baumgartner What influences the outcome of valve replacement in critical aortic stenosis? Heart, October 1, 2005; 91(10): 1254 - 1256. [Abstract] [Full Text] [PDF]

				R. G. Fuster, J. A. Montero Argudo, O. G. Albarova, F. Hornero Sos, S. Canovas Lopez, M. Bueno Codoner, J. A. Buendia Minano, and I. Rodriguez Albarran Left ventricular mass index as a prognostic factor in patients with severe aortic stenosis and ventricular dysfunction Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 260 - 266. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gino Gerosa Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tarantini, G. Articles by Iliceto, S. Search for Related Content PubMed PubMed Citation Articles by Tarantini, G. Articles by Iliceto, S. Related Collections Valve disease